Articles

  • 2 days ago | endocrinologyadvisor.com | Ron Goldberg

    Compared with pooled cohort equations (PCEs), the American Heart Association’s Predicting Risk of Cardiovascular Disease Events (PREVENT) equations can better predict 10-year ASCVD risk among US adults, across sex and racial and ethnic groups, according to study findings published in the Journal of the American Heart Association.

  • 2 days ago | clinicaladvisor.com | Ron Goldberg

    Sleep duration and sleep quality among older adults may be mediated by media use and demographic factors, according to study results presented at the American Psychiatric Association Annual Meeting, held virtually from May 17 to 21, 2025, in Los Angeles, California. Researchers sought to describe media-use preferences among older adults and how that usage impacts sleep duration and quality.

  • 3 days ago | gastroenterologyadvisor.com | Ron Goldberg

    Guselkumab does not meaningfully affect liver fibrosis progression among patients with psoriasis, although early treatment is crucial to mitigate risk, according to study findings published in The Journal of Dermatology. Psoriasis has been associated with various comorbidities that significantly increase the risk for liver fibrosis, but little is known about how treatment for psoriasis affects this risk.

  • 3 days ago | rheumatologyadvisor.com | Ron Goldberg

    Metformin has a moderate although statistically significant effect on reducing knee pain among patients with knee osteoarthritis and overweight or obesity, according to study findings published in the Journal of the American Medical Association. Metformin, currently used as first-line therapy for type 2 diabetes, also reduces inflammation among people with and without diabetes.

  • 3 days ago | endocrinologyadvisor.com | Ron Goldberg

    In pulmonary arterial hypertension (PAH), 5-year mortality is similar with and without obesity, even though patients with obesity have more comorbidities and worse functional capacity, according to study findings published in Chest. Obesity is a frequent comorbidity among patients with PAH. Researchers assessed clinical characteristics and prognosis of patients with PAH with vs without obesity, as well as risk stratification tool performance for PAH with obesity.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →